Marco Mazzocchi

Marco Mazzocchi

Auto-generated profile, based on publicly available information

Marco Mazzocchi

Galeazzi Orthopaedic Institute, I.R.C.C.S. (Scientific Institute for Research, Hospitalization and Health Care), Milan, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2008 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
MOMaria Giuseppina Onesti
Maria Giuseppina Onesti
CMCristiano Monarca
Cristiano Monarca
MRMaria Ida Rizzo
Maria Ida Rizzo
MMMarco Mazzocchi
Marco Mazzocchi
NSNicolò Scuderi
Nicolò Scuderi

16 November 2010 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
NSNicolò Scuderi
Nicolò Scuderi
LDLuca A. Dessy
Luca A. Dessy
EBErnesto M. Buccheri
Ernesto M. Buccheri
FMFrancesco Marchetti
Francesco Marchetti
MMMarco Mazzocchi
Marco Mazzocchi
CACarmine Alfano
Carmine Alfano

9 September 2021
Verified
Conference Paper
Open access
PDF file
MMM Mazzocchi
M Mazzocchi
BMB Mascia
B Mascia
FRF Riccardi
F Riccardi
DPD Passador
D Passador
MFM Ferrari
M Ferrari
FMF Mojoli
F Mojoli
Background and Aims Herpes Zoster reactivation causes inflammatory and hemorrhagic reaction in the posterior roots of spinal nerves and sensitive ganglia. Postherpetic neuralgia (PHN)1 is a neuropathic pain that occurs in 25% of patients older than 502,3. Pharmacological therapy is often uneffective; intrathecal steroid injections and nerve blocks may be tried4. Serratus anterior plane block (SAPB)5 could provide effective analgesia. Methods We treated 2 female patients with PHN, unresponsive to medical therapies, 56 and 74 yo; pain was localized in the antero-lateral area of thorax, limiting free movements of ipsilateral arm. Pain was strong (NRS score 8 and 10), stabbing and burning, exacerbating in absence of stimuli and without relief during the night. We performed an ultrasound-guided SAPB with 0.25%-levobupivacaine 30 ml and dexamethasone 8 mg at 5th intercostal space. Results Both patients had immediate pain relief: NRS was 2–3 after 10 minutes, 0–1 after 2 hours. Benefit was substantially maintained over time: at 48 hours, resumption of pain was mild (NRS 2) in the first patient, moderate (NRS 4–5) in the second; in this patient we decided to perform another injection. NRS finally decreased to 2–3 and there was no need for further injections. At two months there was absence of pain for both. Conclusions Long-lasting SAPB with local anesthetic and steroids could be a safe and effective way to treat resistant PHN, and it should be performed as soon as possible to avoid incipit of chronic pain and improve patient quality of life and outcome. Further studies are necessary to confirm our preliminary data.

9 September 2021
Verified
Conference Paper
Open access
PDF file
MMM Mazzocchi
M Mazzocchi
BMB Mascia
B Mascia
SBS Bonaiti
S Bonaiti
APA Pellegrini
A Pellegrini
ACA Colombo
A Colombo
FMF Mojoli
F Mojoli
Background and Aims 10% of polytraumatized patients have multiple rib fractures. Associated severe pain can lead to hypoventilation and respiratory complications in 31% of cases1. ‘Opioid-sparing analgesia’ as epidural and multimodal analgesia are recommended2. We hypotize that SAPB3,4 can provide effective, safe and long-lasting analgesia (thanks to dexamethasone added to local anaesthetic) and reduce respiratory complications, enhancing recovery of a better mechanical lung function. Methods 15 patients(age 64±15) hospitalized for polytrauma with MRF(8±4) and severe pain(NRS> 4), impairing maximal inspiration and coughing, were treated with multimodal analgesia + SAPB(ethical committee approval obtained). We injected levobupivacaine 0.25% 30 ml and dexamethasone (8 mg) within the myofascial plane of serratus anterior. We registered respiratory rate(RR), heart rate(HR) and NRS at rest(NRSrest), during maximal inspiration(NRSdeep) and coughing(NRScough) before SAPB(T0), after 15 minutes(T1) and after 4 hours(T2). At T0 and T2, lung ultrasound(LUS) and diaphragmatic ultrasound(DUS) were performed. Incidence of opioid-related side effects and respiratory complications were recorded. Results We observed a significant reduction in NRSrest, NRSdeep, NRScough, HR and RR at both T1 and T2 in all patients. LUS revealed a significant improvement in lung aeration, DUS showed a significant increase in diaphragm excursion. Duration of analgesia was greater than 30 hours in most patients, greater than 48 hours in almost 50%. No patient asked for rescue-analgesia. No patient had respiratory complications. Conclusions Both clinical and instrumental data suggest that SAPB is safe and provides effective opioid-sparing analgesia. Pain reduction allows improvement in pulmonary aeration and diaphragmatic function, suggesting a possible role in prevention of pulmonary complications.